-
EP3010905
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3010905
| EP3010905 - SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 04.05.2018 Database last updated on 26.06.2024 | |
| Former | Request for examination was made Status updated on 28.01.2018 | Most recent event Tooltip | 04.05.2018 | Application deemed to be withdrawn | published on 06.06.2018 [2018/23] | Applicant(s) | For all designated states Connexios Life Sciences Pvt. Ltd. No.49, Shilpa Vidya First Main Road JP Nagar 3rd Phase Bangalore 560078 / IN | [N/P] |
| Former [2016/37] | For all designated states Connexios Life Sciences Pvt. Ltd. No.49 Shilpa Vidya First Main Road J P Nagar 3rd Phase Bangalore 560 078 / IN | ||
| Former [2016/17] | For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Inventor(s) | 01 /
MADANAHALLI RANGANATH RAO, Jagannath Connexios Life Sciences Pvt. Ltd. No.49 Shilpa Vidya First Main Road J P Nagar 3rd Phase Bangalore 560078 / IN | 02 /
GURRAM RANGA, Madhavan Connexios Life Sciences Pvt. Ltd. No.49 Shilpa Vidya First Main Road J P Nagar 3rd Phase Bangalore 560078 / IN | 03 /
PACHIYAPPAN, Shanmugam Connexios Life Sciences Pvt. Ltd. No.49 Shilpa Vidya First Main Road J P Nagar 3rd Phase Bangalore 560078 / IN | [2016/17] | Representative(s) | Games, Robert Harland, et al Albright IP Limited County House Bayshill Road Cheltenham, Glos. GL50 3BA / GB | [N/P] |
| Former [2016/17] | Simon, Elke Anna Maria, et al Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Application number, filing date | 14731608.7 | 17.06.2014 | [2016/17] | WO2014EP62684 | Priority number, date | IN2013CHE2685 | 20.06.2013 Original published format: IN CH26852013 | [2016/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014202580 | Date: | 24.12.2014 | Language: | EN | [2014/52] | Type: | A1 Application with search report | No.: | EP3010905 | Date: | 27.04.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.12.2014 takes the place of the publication of the European patent application. | [2016/17] | Search report(s) | International search report - published on: | EP | 24.12.2014 | Classification | IPC: | C07D401/14, C07D401/04, C07D401/06, C07D401/10, C07D403/04, C07D403/08, C07D403/10, C07D413/10, C07D209/34, A61K31/404, A61K31/41, A61K31/4427, A61P3/10 | [2016/17] | CPC: |
C07D209/96 (EP,US);
A61K31/403 (EP,US);
A61K31/404 (EP,US);
A61K31/41 (EP,US);
A61K31/4155 (EP,US);
A61K31/416 (EP,US);
A61K31/4192 (EP,US);
A61K31/4196 (EP,US);
A61K31/437 (EP,US);
A61K31/4439 (EP,US);
A61K31/5377 (EP,US);
A61K45/06 (US);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
C07D209/34 (EP,US);
C07D401/04 (EP,US);
C07D401/06 (EP,US);
C07D401/10 (EP,US);
C07D401/14 (EP,US);
C07D403/04 (EP,US);
C07D403/08 (EP,US);
C07D403/10 (EP,US);
C07D413/10 (EP,US);
C07D471/04 (EP,US);
Y02A50/30 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/17] | Title | German: | SPIRO-SUBSTITUIERTE OXINDOLDERIVATE MIT AMPK-AKTIVITÄT | [2016/17] | English: | SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY | [2016/17] | French: | DÉRIVÉS D'OXINDOLE SPIRO-SUBSTITUÉS AYANT UNE ACTIVITÉ SUR AMPK | [2016/17] | Entry into regional phase | 20.01.2016 | National basic fee paid | 20.01.2016 | Designation fee(s) paid | 20.01.2016 | Examination fee paid | Examination procedure | 20.01.2016 | Examination requested [2016/17] | 11.08.2016 | Amendment by applicant (claims and/or description) | 03.01.2018 | Application deemed to be withdrawn, date of legal effect [2018/23] | 29.01.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2018/23] | Fees paid | Renewal fee | 29.06.2016 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.06.2017 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO0238544 (LILLY CO ELI [US], et al) [A] 1-24* page 55; claim 1 *; | [A]WO2011069298 (HOFFMANN LA ROCHE [CH], et al) [A] 1-24 * page 1, line 1 - line 5 * * page 166; claim 1 *; | [A]WO2012000103 (UNIV HEALTH NETWORK [CA], et al) [A] 1-24 * page 66; table 1; compound 2 * * page 69; table 1; compound 12 * * page 72 - page 73; table 1; compounds 35, 40 *; | [A] - DAVID W. ROBERTSON ET AL, "Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-spiro[cycloalkane-1,3'-[3H]indol]-2'(1'H)-ones", JOURNAL OF MEDICINAL CHEMISTRY, (19870501), vol. 30, no. 5, doi:10.1021/jm00388a014, ISSN 0022-2623, pages 824 - 829, XP055128253 [A] 1-24 * page 825; table I; compounds 10-11 * DOI: http://dx.doi.org/10.1021/jm00388a014 |